Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
124 studies found for:    "Pneumonia, Bacterial"
Show Display Options
RSS Create an RSS feed from your search for:
"Pneumonia, Bacterial"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia
Condition: Pneumonia, Bacterial
Intervention: Drug: daptomycin
2 Completed A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia
Condition: Pneumonia, Bacterial
Interventions: Drug: Ceftriaxone;   Drug: beta-lactam
3 Recruiting A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia
Condition: Pneumonia, Bacterial
Intervention: Drug: ME1100 inhalation solution
4 Completed Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae
Condition: Pneumonia, Bacterial
Intervention: Drug: daptomycin
5 Completed Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
Condition: Pneumonia, Bacterial
Interventions: Drug: Amikacin fosfomycin inhalation solution;   Drug: Aerosolized placebo
6 Completed Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia
Interventions: Drug: Levofloxacin;   Drug: CEM-101
7 Completed
Has Results
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Conditions: Pneumonia, Bacterial;   Community-acquired
Interventions: Drug: Ceftaroline;   Drug: Levofloxacin
8 Completed Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit
Condition: Pneumonia, Bacterial
Interventions: Other: 5 Days of Antibiotics;   Other: 7 Days of Antibiotics therapy for pneumonia
9 Recruiting Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)
Condition: Bacterial Pneumonia
Interventions: Drug: Imipenem;   Drug: Relebactam;   Drug: Cilastatin;   Drug: Piperacillin;   Drug: Tazobactam;   Drug: Linezolid
10 Terminated Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia (CABP)
Interventions: Drug: JNJ-32729463;   Drug: moxifloxacin;   Drug: JNJ-32729463 (Open-Label)
11 Completed
Has Results
A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
Conditions: Community-Acquired Bacterial Pneumonia;   Lung Infection of Individual Not Recently Hospitalized
Interventions: Drug: Ceftaroline;   Drug: Ceftriaxone
12 Recruiting Safety and Efficacy of Solithromycin in Adolescents and Children With Community-acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial Pneumonia
Interventions: Drug: Solithromycin;   Drug: Standard of Care
13 Completed Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial Pneumonia
Interventions: Drug: Solithromycin;   Drug: Moxifloxacin;   Other: Placebo to match solithromycin
14 Completed Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
Condition: Community-acquired Bacterial Pneumonia
Interventions: Drug: Solithromycin;   Drug: Moxifloxacin
15 Withdrawn Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia
Condition: Community-Acquired Bacterial Pneumonia (CABP)
Intervention: Drug: Ceftaroline fosamil
16 Completed
Has Results
The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)
Condition: Pneumonia, Bacterial
Intervention: Drug: ampicillin sodium/sulbactam sodium
17 Withdrawn Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization
Condition: Pneumonia, Bacterial
Interventions: Drug: Amikacin Fosfomycin Inhalation Solution;   Drug: Aerosolized placebo
18 Recruiting Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
Condition: Pneumonia, Bacterial
Interventions: Drug: Amikacin Inhalation Solution (BAY41-6551);   Drug: Aerosolized Placebo
19 Recruiting Inhaled Amikacin Solution (BAY 41-6551) as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia
Condition: Pneumonia, Bacterial
Interventions: Drug: Amikacin Inhalation Solution (BAY41-6551);   Drug: Aerosolized Placebo
20 Completed
Has Results
A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization
Condition: Pneumonia, Bacterial
Interventions: Drug: sulopenem and PF-03709270;   Drug: Sulopenem and PF-03709270;   Drug: Ceftriaxone and amoxicillin/clavulanate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.